{"id":"W4408144500","doi":"10.1177/22143602241305511","title":"Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions","year":2025,"lang":"en","type":"article","venue":"Journal of Neuromuscular Diseases","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Sanofi Genzyme; Genentech; Grifols; Japan Blood Products Organization; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Biogen; Novo Nordisk; Sanofi; AstraZeneca; Pfizer; Amgen","keywords":"Myasthenia gravis; Medicine; Interim analysis; Adverse effect; Internal medicine; Neuromuscular disease; Autoantibody; Clinical trial; Antibody; Immunology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01975705,0.001729849,0.005624496,0.000846763,0.000255219,0.001633855,0.0007908631,0.001338253,0.002585661],"category_scores_gemma":[0.01359796,0.0007412544,0.01463998,0.001124174,0.0004699621,0.0009344504,0.001144407,0.001246014,0.0003391582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006355918,"about_ca_system_score_gemma":0.001038889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000774871,"about_ca_topic_score_gemma":0.00217576,"domain_scores_codex":[0.9881281,0.008688285,0.001003741,0.001034736,0.0008058349,0.0003393454],"domain_scores_gemma":[0.9902312,0.004121923,0.002921334,0.001508407,0.0008110749,0.0004060632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5755228,0.0006827759,0.01688571,0.008682915,0.3455778,0.0001514377,0.000131953,0.001666467,0.003639744,0.0001704115,0.002152,0.04473591],"study_design_scores_gemma":[0.2368576,0.04290588,0.1336421,0.001140045,0.5734496,0.0004366543,0.0001773901,0.002943143,0.001415382,0.000706737,0.006138917,0.0001864779],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8218234,0.1552073,0.005392456,0.0006277425,0.0006400045,0.003717092,0.008751914,0.0004362429,0.003403807],"genre_scores_gemma":[0.9809639,0.009670816,0.001998152,0.0006918575,0.0003316311,0.001641496,0.003967701,0.00005691098,0.0006775525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01975705,"threshold_uncertainty_score":0.1044865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02857169951259211,"score_gpt":0.3718732683308484,"score_spread":0.3433015688182563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}